{"id":"https://openalex.org/W4404151128","doi":"https://doi.org/10.1111/bjh.19819","title":"Clinical outcomes in patients in any phase of CML treated with ponatinib in France\u2014Data from the TOPASE observational study","display_name":"Clinical outcomes in patients in any phase of CML treated with ponatinib in France\u2014Data from the TOPASE observational study","publication_year":2024,"publication_date":"2024-11-06","ids":{"openalex":"https://openalex.org/W4404151128","doi":"https://doi.org/10.1111/bjh.19819","pmid":"https://pubmed.ncbi.nlm.nih.gov/39506529","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11637719"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.19819","doi":"https://doi.org/10.1111/bjh.19819","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.19819","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.19819","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.19819","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004066423","display_name":"Fran\u00e7oise Huguet","orcid":"https://orcid.org/0000-0002-9576-8578","observed_orcids":["https://orcid.org/0000-0002-9576-8578","https://orcid.org/0000-0002-5302-5784"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Huguet","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haematology Department, Cancer University Institute, University Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haematology Department, Cancer University Institute, University Hospital, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112296198","display_name":"Agn\u00e8s Guerci\u2010Bresler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Guerci\u2010Bresler","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haematology Department, Regional University Hospital Brabois, Vandoeuvre-les-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haematology Department, Regional University Hospital Brabois, Vandoeuvre-les-Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064243705","display_name":"Gabrielle Roth-Gu\u00e9pin","orcid":"https://orcid.org/0009-0006-9270-9472","observed_orcids":["https://orcid.org/0009-0006-9270-9472"]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Roth\u2010Guepin","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haematology Department, Regional University Hospital Brabois, Vandoeuvre-les-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haematology Department, Regional University Hospital Brabois, Vandoeuvre-les-Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085118674","display_name":"\u00c9milie Cayssials","orcid":"https://orcid.org/0000-0003-1654-5948","observed_orcids":["https://orcid.org/0000-0003-1654-5948"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Cayssials","raw_affiliation_strings":["CIC INSERM 1402  Poitiers France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haematoloy and Cellular Therapy Department, University Hospital, Poitiers, France"],"raw_orcid":"https://orcid.org/0000-0003-1654-5948","affiliations":[{"raw_affiliation_string":"CIC INSERM 1402  Poitiers France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haematoloy and Cellular Therapy Department, University Hospital, Poitiers, France","institution_ids":["https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087543786","display_name":"Bohrane Slama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Slama","raw_affiliation_strings":["Hospital Centre, Avignon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Centre, Avignon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112941743","display_name":"Alice Maria Santagostino","orcid":"https://orcid.org/0009-0007-0756-5134","observed_orcids":["https://orcid.org/0009-0007-0756-5134"]},"institutions":[{"id":"https://openalex.org/I4210123877","display_name":"Centre Hospitalier de Troyes","ror":"https://ror.org/02vm0aw48","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123877"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Santagostino","raw_affiliation_strings":["Haematology Department, Hospital Centre, Troyes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology Department, Hospital Centre, Troyes, France","institution_ids":["https://openalex.org/I4210123877"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011833868","display_name":"Am\u00e9lie Penot","orcid":"https://orcid.org/0009-0006-8275-5686","observed_orcids":["https://orcid.org/0009-0006-8275-5686"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210118469","display_name":"Centre Hospitalier Universitaire de Limoges","ror":"https://ror.org/01tc2d264","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210118469"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Penot","raw_affiliation_strings":["Department of Clinical Haematology and Cellular Therapy, University Hospital, Limoges, France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Haematology and Cellular Therapy, University Hospital, Limoges, France","institution_ids":["https://openalex.org/I4210118469"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034854878","display_name":"Philippe Quittet","orcid":"https://orcid.org/0000-0003-2324-5660","observed_orcids":["https://orcid.org/0000-0003-2324-5660"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Quittet","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haematology Clinical Department, University Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haematology Clinical Department, University Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044166434","display_name":"Pascale Cony\u2010Makhoul","orcid":"https://orcid.org/0000-0002-1633-6479","observed_orcids":["https://orcid.org/0000-0002-1633-6479"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210133838","display_name":"Centre Hospitalier Annecy Genevois","ror":"https://ror.org/03deam493","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210133838"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Cony\u2010Makhoul","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Hospital Centre, Annecy Genevois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Hospital Centre, Annecy Genevois, France","institution_ids":["https://openalex.org/I4210133838"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Saad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094684","display_name":"Centre Hospitalier de B\u00e9ziers","ror":"https://ror.org/00p7wry37","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210094684"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Saad","raw_affiliation_strings":["Haematology Department Hospital Centre  B\u00e9ziers France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology Department Hospital Centre  B\u00e9ziers France","institution_ids":["https://openalex.org/I4210094684"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. N. Bastie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I177064439","display_name":"Universit\u00e9 de Bourgogne","ror":"https://ror.org/03k1bsr36","country_code":"FR","type":"education","lineage":["https://openalex.org/I177064439","https://openalex.org/I4405253280"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. N. Bastie","raw_affiliation_strings":["Department of Clinical Haematology, University Hospital and INSERM, UMR 1231 University of Burgundy & Franche\u2010Comt\u00e9 Dijon France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Haematology, University Hospital and INSERM, UMR 1231 University of Burgundy & Franche\u2010Comt\u00e9 Dijon France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I177064439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063891068","display_name":"Maya Hacini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109185","display_name":"Centre Hospitalier M\u00e9tropole Savoie","ror":"https://ror.org/01r35jx22","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210109185"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Hacini","raw_affiliation_strings":["Savoie Metropol Hospital Centre  Chamb\u00e9ry France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Savoie Metropol Hospital Centre  Chamb\u00e9ry France","institution_ids":["https://openalex.org/I4210109185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056337631","display_name":"Val\u00e9rie Coiteux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V. Coiteux","raw_affiliation_strings":["Blood Diseases, Allograft and Cell Therapy Unit, Huriez Hospital, Lille, France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood Diseases, Allograft and Cell Therapy Unit, Huriez Hospital, Lille, France","institution_ids":["https://openalex.org/I4210155195"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002402846","display_name":"Madalina Uzunov","orcid":"https://orcid.org/0000-0002-5254-3483","observed_orcids":["https://orcid.org/0000-0002-5254-3483"]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Uzunov","raw_affiliation_strings":["Clinical Haematology Department, Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital, APHP Sorbonne University  Paris France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Haematology Department, Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital, APHP Sorbonne University  Paris France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4210121705"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007454329","display_name":"Lydia Roy","orcid":"https://orcid.org/0000-0002-1833-9673","observed_orcids":["https://orcid.org/0000-0002-1833-9673"]},"institutions":[{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Roy","raw_affiliation_strings":["Clinical Haematology Department, University Hospital Henri Mondor, AP\u2010HP & Health Faculty Paris Est Cr\u00e9teil University (UPEC) Cr\u00e9teil France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France"],"raw_orcid":"https://orcid.org/0000-0002-1833-9673","affiliations":[{"raw_affiliation_string":"Clinical Haematology Department, University Hospital Henri Mondor, AP\u2010HP & Health Faculty Paris Est Cr\u00e9teil University (UPEC) Cr\u00e9teil France","institution_ids":["https://openalex.org/I197681013","https://openalex.org/I4210130325"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086160671","display_name":"L\u00e9na\u00efg Le Clech","orcid":"https://orcid.org/0000-0001-5586-9772","observed_orcids":["https://orcid.org/0000-0001-5586-9772"]},"institutions":[{"id":"https://openalex.org/I4210116491","display_name":"Centre Hospitalier de Cornouaille","ror":"https://ror.org/02pcvrc50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116491"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Le Clech","raw_affiliation_strings":["Haematology Department, Hospital Centre of Cornouaille, Quimper, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology Department, Hospital Centre of Cornouaille, Quimper, France","institution_ids":["https://openalex.org/I4210116491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061164405","display_name":"Marc Gabriel Berger","orcid":"https://orcid.org/0000-0003-1858-0587","observed_orcids":["https://orcid.org/0000-0003-1858-0587"]},"institutions":[{"id":"https://openalex.org/I198244214","display_name":"Universit\u00e9 Clermont Auvergne","ror":"https://ror.org/01a8ajp46","country_code":"FR","type":"education","lineage":["https://openalex.org/I198244214"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210128870","display_name":"Centre Hospitalier Universitaire de Clermont-Ferrand","ror":"https://ror.org/02tcf7a68","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128870"]},{"id":"https://openalex.org/I4405256289","display_name":"Clonal Heterogeneity, Leukemic environment, ThErapy Resistance of chronic leukemias","ror":"https://ror.org/0402qmp47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I198244214","https://openalex.org/I4405256289"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Berger","raw_affiliation_strings":["Biological Haematology, University Hospital Centre, Clermont Ferrand, France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Host Team EA7453 CHELTER, Clermont Auvergne University, Clermont-Ferrand, France"],"raw_orcid":"https://orcid.org/0000-0003-1858-0587","affiliations":[{"raw_affiliation_string":"Biological Haematology, University Hospital Centre, Clermont Ferrand, France","institution_ids":["https://openalex.org/I4210128870"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Host Team EA7453 CHELTER, Clermont Auvergne University, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I198244214","https://openalex.org/I4405256289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114560505","display_name":"A. M. Agneray","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"A. M. Agneray","raw_affiliation_strings":["Incyte Biosciences France, Boulogne Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incyte Biosciences France, Boulogne Billancourt, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089215000","display_name":"Emmanuel Messas","orcid":"https://orcid.org/0000-0003-3214-7501","observed_orcids":["https://orcid.org/0000-0003-3214-7501"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210131199","display_name":"Paris Cardiovascular Research Center","ror":"https://ror.org/03gvnh520","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210131199"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Messas","raw_affiliation_strings":["H\u00f4pital Europ\u00e9en Georges Pompidou Inserm UMR 970 team2, HYPERVASC Department  Paris France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Europ\u00e9en Georges Pompidou Inserm UMR 970 team2, HYPERVASC Department  Paris France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210102325","https://openalex.org/I4210131199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070207000","display_name":"Gabriel \u00c9tienne","orcid":"https://orcid.org/0000-0001-7600-4954","observed_orcids":["https://orcid.org/0000-0001-7600-4954"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Etienne","raw_affiliation_strings":["Bergoni\u00e9 Institute  Bordeaux France","Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France"],"raw_orcid":"https://orcid.org/0000-0001-7600-4954","affiliations":[{"raw_affiliation_string":"Bergoni\u00e9 Institute  Bordeaux France","institution_ids":["https://openalex.org/I4210134409"]},{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041347850","display_name":"Ali G. Turhan","orcid":"https://orcid.org/0000-0002-4861-0137","observed_orcids":["https://orcid.org/0000-0002-4861-0137"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210128926","display_name":"Genopole (France)","ror":"https://ror.org/0380k9k47","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210128926"]},{"id":"https://openalex.org/I4210162942","display_name":"Bic\u00eatre Hospital","ror":"https://ror.org/05c9p1x46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210162942","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Turhan","raw_affiliation_strings":["APHP Paris Saclay University Hospitals, Bicetre Hospital, Le Kremlin-Bicetre, France","CITHERA (Center for IPSC Therapies), Genopole, Evry, France","INSERM UMRS_1310, Villejuif, France","Merican Hospital of Paris, Neuilly Sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APHP Paris Saclay University Hospitals, Bicetre Hospital, Le Kremlin-Bicetre, France","institution_ids":["https://openalex.org/I4210162942"]},{"raw_affiliation_string":"CITHERA (Center for IPSC Therapies), Genopole, Evry, France","institution_ids":["https://openalex.org/I4210128926"]},{"raw_affiliation_string":"INSERM UMRS_1310, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Merican Hospital of Paris, Neuilly Sur Seine, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082189560","display_name":"Franck Emmanuel Nicolini","orcid":"https://orcid.org/0000-0002-3192-4199","observed_orcids":["https://orcid.org/0000-0002-3192-4199","https://orcid.org/0000-0003-3779-1996","https://orcid.org/0000-0002-3499-5080"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. E. Nicolini","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haematology Department and INSERM U1052 CRCL Centre L\u00e9on B\u00e9rard  Lyon France"],"raw_orcid":"https://orcid.org/0000-0002-3192-4199","affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haematology Department and INSERM U1052 CRCL Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052564121","display_name":"Philippe H. Rousselot","orcid":"https://orcid.org/0000-0003-3238-4494","observed_orcids":["https://orcid.org/0000-0003-3238-4494"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210159263","display_name":"Centre Hospitalier de Versailles","ror":"https://ror.org/053evvt91","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159263"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Rousselot","raw_affiliation_strings":["Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","Haeamatology Department Centre Hospitalier de Versailles, Versailles, France","U1184 Paris\u2010Saclay University  Gif\u2010sur\u2010Yvette France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fi LMC Centre L\u00e9on B\u00e9rard  Lyon France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"Haeamatology Department Centre Hospitalier de Versailles, Versailles, France","institution_ids":["https://openalex.org/I4210159263"]},{"raw_affiliation_string":"U1184 Paris\u2010Saclay University  Gif\u2010sur\u2010Yvette France","institution_ids":["https://openalex.org/I277688954"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":29,"corresponding_author_ids":["https://openalex.org/A5114560505"],"corresponding_institution_ids":[],"apc_list":{"value":4940,"currency":"USD","value_usd":4940},"apc_paid":{"value":4940,"currency":"USD","value_usd":4940},"fwci":1.6683,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.83009436,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"205","issue":"6","first_page":"2295","last_page":"2304"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ponatinib","display_name":"ponatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.8679999709129333},{"id":"https://openalex.org/keywords/chronic-phase-cml","display_name":"chronic phase CML","score":0.593999981880188},{"id":"https://openalex.org/keywords/accelerated-phase-cml","display_name":"accelerated phase CML","score":0.9409999847412109},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.7599999904632568},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.8629999756813049},{"id":"https://openalex.org/keywords/major-molecular-response","display_name":"major molecular response","score":0.6890000104904175},{"id":"https://openalex.org/keywords/arterial-occlusive-events","display_name":"arterial occlusive events","score":0.8880000114440918},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8809999823570251},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.8198089599609375},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7066807150840759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5887277126312256},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40671008825302124},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.29763081669807434},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.26505815982818604},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.22142860293388367}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bjh.19819","doi":"https://doi.org/10.1111/bjh.19819","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.19819","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.19819","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11637719","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11637719","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11637719/pdf/BJH-205-2295.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Haematol","raw_type":"Text"},{"id":"pmid:39506529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39506529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/bjh.19819","doi":"https://doi.org/10.1111/bjh.19819","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.19819","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.19819","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404151128.pdf","grobid_xml":"https://content.openalex.org/works/W4404151128.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W14019567","https://openalex.org/W1523946531","https://openalex.org/W1965429870","https://openalex.org/W1968747503","https://openalex.org/W2031161823","https://openalex.org/W2061014293","https://openalex.org/W2076720738","https://openalex.org/W2144770959","https://openalex.org/W2147109509","https://openalex.org/W2163526866","https://openalex.org/W2169252817","https://openalex.org/W2296398034","https://openalex.org/W2495072828","https://openalex.org/W2526416288","https://openalex.org/W2590897015","https://openalex.org/W2790692615","https://openalex.org/W2979771750","https://openalex.org/W3009751715","https://openalex.org/W3159331896","https://openalex.org/W3194203975","https://openalex.org/W4200448927","https://openalex.org/W4205414597","https://openalex.org/W4283015980","https://openalex.org/W4283328961","https://openalex.org/W4288701141","https://openalex.org/W4294307875","https://openalex.org/W4383711235"],"related_works":["https://openalex.org/W3182122744","https://openalex.org/W1814874339","https://openalex.org/W4310107918","https://openalex.org/W7162135663","https://openalex.org/W2790692615","https://openalex.org/W2608124271","https://openalex.org/W2989237382","https://openalex.org/W4206854338","https://openalex.org/W2593536726","https://openalex.org/W2577879486"],"abstract_inverted_index":{"The":[0,62,86],"TOPASE":[1],"study":[2],"was":[3,69,91,159],"set":[4],"up":[5],"to":[6],"evaluate":[7],"the":[8,53,170],"outcomes":[9],"of":[10,52,60,136,144,172],"chronic":[11,34],"myeloid":[12],"leukaemia":[13],"[CML]":[14],"patients":[15,55,79,147,163,178],"treated":[16],"with":[17,179],"ponatinib":[18,173],"(PON)":[19],"in":[20,24,33,38,44,57,67,72,77,83,99,109,133,161,174,184],"a":[21,140],"real-world":[22],"setting":[23],"France.":[25],"One":[26],"hundred":[27],"and":[28,42,80,101],"twenty":[29],"CML":[30],"patients,":[31,74,115],"105":[32],"phase":[35,40,46],"(CP),":[36],"8":[37],"accelerated":[39],"(AP)":[41],"7":[43],"blastic":[45],"(BP)":[47],"were":[48,56,118],"included.":[49],"Fifty-one":[50],"(49%)":[51],"CP-CML":[54,68,100,113],"third":[58],"line":[59,135],"treatment.":[61],"trigger":[63],"for":[64,131],"PON":[65],"initiation":[66,90],"'poor":[70,75],"response'":[71],"67":[73],"tolerance'":[76],"28":[78],"'response":[81],"enhancement'":[82],"seven":[84],"patients.":[85,186],"median":[87],"dose":[88],"at":[89,123,127,149],"30":[92],"mg/day":[93,103],"[Q1;":[94,104],"Q3":[95,105],"=":[96,106],"15;":[97],"30]":[98],"45":[102],"30;":[107],"45]":[108],"AP/BP-CML.":[110],"Of":[111],"98":[112],"evaluable":[114],"72":[116],"(73.5%)":[117],"considered":[119],"as":[120],"responders":[121],"(MMR)":[122],"one":[124,151],"time":[125],"point":[126],"least":[128,150],"once,":[129],"especially":[130],"those":[132],"second":[134],"treatment":[137],"and/or":[138],"presenting":[139],"T315I":[141],"mutation.":[142],"Ninety-six":[143],"120":[145],"(80%)":[146],"reported":[148,160],"adverse":[152],"event.":[153],"An":[154],"arterial":[155],"occlusive":[156],"event":[157],"(AOE)":[158],"11":[162],"(9.2%).":[164],"Thus,":[165],"these":[166],"real-life":[167],"data":[168],"confirm":[169],"potency":[171],"resistant":[175],"or":[176],"intolerant":[177],"an":[180],"acceptable":[181],"safety":[182],"profile":[183],"non-selected":[185],"NCT":[187],"number:":[188],"NCT04048564.":[189]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-11-08T00:00:00"}